
Sign up to save your podcasts
Or


Libby Toudouze, a partner and money manager at Cushing Asset Management, says Williams Partners is in the sweet spot of the energy "renaissance." Michael Scanlon, a money manager at Manulife Asset Management, previews Apple earnings. Max Nisen, a Bloomberg Gadfly columnist covering health care, discusses Eli Lilly and Pfizer earnings, Teva's plunge after patents were invalidated and Donald Trump's meeting with the pharmaceutical industry representatives today. Finally, Patrick Donahue, a German government reporter for Bloomberg in Berlin, discusses Trump adviser Peter Navarro criticizing Germany for exploiting an "undervalued" euro.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
Libby Toudouze, a partner and money manager at Cushing Asset Management, says Williams Partners is in the sweet spot of the energy "renaissance." Michael Scanlon, a money manager at Manulife Asset Management, previews Apple earnings. Max Nisen, a Bloomberg Gadfly columnist covering health care, discusses Eli Lilly and Pfizer earnings, Teva's plunge after patents were invalidated and Donald Trump's meeting with the pharmaceutical industry representatives today. Finally, Patrick Donahue, a German government reporter for Bloomberg in Berlin, discusses Trump adviser Peter Navarro criticizing Germany for exploiting an "undervalued" euro.
See omnystudio.com/listener for privacy information.

975 Listeners

1,170 Listeners

2,188 Listeners

422 Listeners

970 Listeners

197 Listeners

1,039 Listeners

186 Listeners

71 Listeners

1,303 Listeners

63 Listeners

78 Listeners

30 Listeners

59 Listeners

5 Listeners

58 Listeners

233 Listeners

233 Listeners

65 Listeners

84 Listeners

74 Listeners

77 Listeners

85 Listeners

402 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

23 Listeners